BLFS
BioLife Solutions Inc
36.70$
-0.4%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | +288.1% | -48.3% | +437.1% | -174.2% | – | – | – | +138.6% | |
| – | +33.0% | +7.3% | -8.0% | -0.2% | +431.7% | +182.0% | +153.8% | +28.0% | -25.4% | -55.3% | -14.6% | |
| – | +122.7% | +51.9% | +63.5% | +19.6% | +100.3% | +96.5% | +133.3% | +81.5% | +25.0% | -2.4% | -25.6% | |
| – | +15.4% | +556.8% | -39.2% | +0.1% | +584.6% | -108.1% | – | – | – | – | – | |
| – | – | – | – | -1,196.0% | – | – | – | – | – | -84.5% | -4,024.7% | |
| – | +140.4% | -11.3% | -88.6% | +247.8% | +35.0% | +586.4% | +81.0% | +23.9% | -38.6% | -49.4% | +510.4% | |
| – | – | -90.7% | -136.6% | +4,413.9% | +315.7% | -12.2% | -46.7% | +359.7% | – | +226.8% | -222.7% | |
| – | -0.2% | +0.0% | +0.2% | +310.4% | -100.0% | – | – | – | – | – | – | |
| – | -97.3% | -54.8% | +2,260.0% | -208.0% | – | +5,691.0% | – | – | – | – | – | |
| – | +0.0% | +0.0% | -67.3% | -105.7% | – | +0.0% | -394.1% | – | -102.8% | +1,226.9% | +51.3% | |
| – | -97.3% | +758.8% | +51.4% | +486.9% | -94.3% | +6,295.9% | -102.7% | – | -35.1% | -164.0% | +61.0% | |
| – | -115.3% | – | – | +356.4% | -200.9% | – | -124.5% | – | – | +275.5% | -204.0% | |
| – | – | – | – | +300.7% | -70.9% | +249.8% | -802.5% | – | – | – | -92.0% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.